CROI 2024 BHIVA working group summary
- PMID: 39257023
- DOI: 10.1111/hiv.13705
CROI 2024 BHIVA working group summary
Abstract
The Conference on Retroviruses and Opportunistic Infections (CROI) is usually the most significant HIV conference of the year in terms of basic and clinical scientific output. CROI 2024 in Denver, USA, felt very much back to 'business as usual' following COVID-19 disruptions that had impacted preceding years, but also felt more global and outward- facing. The British HIV Association supports a working group to attend CROI annually and deliver feedback in the UK. This article summarizes the highlights from that meeting.
Keywords: CROI; HIV.
© 2024 British HIV Association.
References
REFERENCES
-
- Medland NA, McManus H, Bavinton B, et al. HIV incidence in users of HIV preexposure prophylaxis in Australia: a whole‐of‐population analysis. CROI. 2024; Oral Abstract 166.
-
- Tao L, Juan Yang JC, Hojilla, et al. PrEP non‐persistence and new HIV diagnoses: a real ‐world analysis of >120,000 people prescribed PrEP. CROI. 2024; Abstract 1124.
-
- Bassett IV, Yan J, Govere S, et al. Persistence on contraception and PrEP in hair salons in South Africa. CROI. 2024; Abstract 1253.
-
- Cassidy WC, Lindsay B, Siyambango M, et al. PrEP uptake and persistence among incarcerated people in Zambia: early results from a cohort study. CROI. 2024; Abstract 1127.
-
- Heffron R, Etyang L, Nyerere B, et al. Mugo. Phone calls for PrEP persistence in Kenyan women in postabortal care: a cluster randomised trial. CROI. 2024; Abstract 169.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources